FAO-fueled OXPHOS and NRF2-mediated stress resilience in MICs drive lymph node metastasis

S Shan-Shan Li (Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital) B Baifeng Zhang (Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong) C Cuicui Huang (Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong) Y Yuying Fu (Advanced Energy Science and Technology Guangdong Laboratory) Y Yuying Zhao (Key Lab of Biomass Energy and Material, Jiangsu Province; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Institute of Chemical Industry of Forest Products) L Lanqi Gong (Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong) Y Yanan Tan (Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital) H Huali Wang (Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital) W Wenqi Chen (Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital) J Jie Luo Y Yu Zhang (Xiangya Hospital, Central South University Changsha China) S Stephanie Ma (Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital) L Li Fu (College of Materials and Environmental Engineering, Hangzhou Dianzi University, Hangzhou, China.) C Chenli Liu (State Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences) J Jiandong Huang H Huai-Qiang Ju (Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital) A Anne Wing-Mui Lee (Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital) X Xin-Yuan Guan (Department of Clinical Oncology, The University of Hong Kong)

Abstract

Metastasis is an inefficient process requiring cancer cells to adapt metabolically for survival and colonization in new environments. The contributions of tumor metabolic reprogramming to lymph node (LN) metastasis and its underlying mechanisms remain elusive. Through single-cell RNA sequencing, we identified rare metastasis-initiating cells (MICs) with stem-like properties that drive early LN metastasis. Integrated transcriptome, lipidomic, metabolomic, and functional analyses demonstrated that MICs depend on oxidative phosphorylation (OXPHOS) fueled by fatty acid oxidation (FAO) in the lipid-rich LN microenvironment. Mechanistically, the NRF2-SLC7A11 axis promotes glutathione synthesis to mitigate oxidative stress, thereby enhancing stress resistance and metastatic potential of MICs. Inhibition of NRF2-SLC7A11 reduced LN metastasis and sensitized tumors to cisplatin. Clinically, elevated NRF2-SLC7A11 expression was observed in tumors, with high expression correlating with LN metastasis, chemoresistance, and poor prognosis in esophageal squamous cell carcinoma (ESCC). These findings highlight the pivotal roles of FAO-fueled OXPHOS and NRF2 in LN metastasis and suggest targeting these pathways as a promising therapeutic strategy for metastatic ESCC.

Article Details

Volume / Issue Vol. 122, Issue 15
Published April 15, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (18)

S

Shan-Shan Li

Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital

B

Baifeng Zhang

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong

C

Cuicui Huang

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong

Y

Yuying Fu

Advanced Energy Science and Technology Guangdong Laboratory

Y

Yuying Zhao

Key Lab of Biomass Energy and Material, Jiangsu Province; Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Institute of Chemical Industry of Forest Products

L

Lanqi Gong

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong

Y

Yanan Tan

Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital

H

Huali Wang

Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital

W

Wenqi Chen

Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital

J

Jie Luo

Y

Yu Zhang

Xiangya Hospital, Central South University Changsha China

S

Stephanie Ma

Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital

L

Li Fu

College of Materials and Environmental Engineering, Hangzhou Dianzi University, Hangzhou, China.

C

Chenli Liu

State Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences

J

Jiandong Huang

H

Huai-Qiang Ju

Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital

A

Anne Wing-Mui Lee

Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital

X

Xin-Yuan Guan

Department of Clinical Oncology, The University of Hong Kong